Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Elevated CAR has been associated with adverse outcomes in many conditions, including cancer, sepsis, COVID-19, and cardiovascular diseases. A higher C-reactive protein to albumin ratio (CAR) is ...

A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...

Chronic pain is a common complaint among those with COPD. Columnist Caroline Gainer shares the pain relief strategies that ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

Medscape Medical News, March 19, 2014 COPD Raises Risk for Mild Cognitive ... to first morbidity or mortality compared with placebo treatment in the postmarket COMPASS 2 trial.

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

To achieve the desired results, it may require more sessions over a longer time. IPL skin treatment uses many wavelengths to repair unwanted pigment conditions. During treatment, the light waves pass ...